
产品介绍 评论(0)
物种
Human分子别名
Growth/differentiation factor 6; GDF-6; Bone morphogenetic protein 13 (BMP-13); Growth/differentiation factor 16;Accession
Q6KF10表达序列
Thr336-Arg455
表达宿主
E.coli分子量
15-16 kDa (Reducing)
纯度
>95% by SDS-PAGE.内毒素含量
<0.1EU/μg活性
EC50 < 3.0μg/ml标记
Unconjugated标签
No Tag性状
Lyophilized Powder缓冲体系
4mM HCl
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in 4mM HCl after rapid centrifugation.
储存条件
·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.文献引用
Nature. 1994 Apr 14;368(6472):639-43.
Development. 1999 Mar;126(6):1305-15.
Growth differentiation factor 6 (GDF-6), also known as bone morphogenetic protein 13 (BMP-13), is a member of the transforming growth factor-beta (TGF-β) superfamily of cytokines that plays a critical role in skeletal development and joint maintenance. In humans, GDF-6 is expressed in various tissues, including cartilage, bone, and synovium, and is involved in regulating chondrogenesis, osteogenesis, and joint homeostasis. GDF-6 exerts its biological effects by binding to specific cell surface receptors, such as the BMP receptors, leading to the activation of downstream signaling pathways, including Smad and non-Smad pathways. Through its signaling activities, GDF-6 promotes the differentiation of mesenchymal stem cells into chondrocytes and osteoblasts, as well as the maintenance of cartilage integrity and joint function. GDF-6 is considered a key regulator of skeletal development and joint health, with implications for musculoskeletal disorders and regenerative medicine.
生物活性
Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 2.1-2.8 ug/ml.
电泳
2μg (R: reducing condition, N: non-reducing condition).







评论(0)